Arcus Biosciences COO Jennifer Jarrett resigns effective March 30, 2026; advisory role through June 2026

Arcus Biosciences, Inc.

COO Jennifer Jarrett resigns effective March 30, 2026; departure not due to any disagreement with company.
Separation agreement includes advisory services through June 30, 2026, and extends post-termination option exercise period to 12 months.
Agreement includes a standard release of claims; final separation agreement to be filed with next 10-Q.
No replacement for COO position has been announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.